The Global Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 7.2 billion in 2017, and is projected to exhibit a CAGR of 10.5% over the forecast period (2018 - 2026).
Halitosis or bad breath according to a National Center for Biotechnology Information (NCBI), affect half of the population in the U.S. and between 50% and 60% of the population in France. Although it occurs due to number of causes, oral hygiene is a major factor. Respiratory system problems, hepatic disease, gastrointestinal disease, hematological or endocrine system disorders, and metabolic conditions can also the cause halitosis.
Other potential factors that contribute to halitosis are endodontic, surgical, and pathologic factors such as exposed tooth pulps and non-vital tooth with fistula draining into the mouth, oral cancer, oral cavity pathologies, and ulcerations, extractions/healing wounds or prosthetics. All these factors cause food or plaque retention area, decay of amino acids, raising bacterial amount, tissue breakdown, and decreasing of saliva flow. These conditions result in the release of volatile compounds causing halitosis.
Treatment for bad breath can vary depending on the cause. For instance, halitosis caused due to a buildup of bacteria (plaque) on teeth can be treated with mouth rinse that kills the bacteria. Furthermore, halitosis caused due to gum diseases can be treated with tooth cleaning procedures.
Manufacturers in halitosis treatment market are focused on development and approval of new products and strategic collaborations with other industry players to gain significant market share. For instance, in 2017, Listerine, a leading market player in halitosis treatment market launched a new Green Tea variant that combines essential oils and green tea extract with fluoride.
Browse 19 Market Data Tables and 23 Figures spread through 155 Pages and in-depth TOC on "Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to halitosis treatment market, click the link below:
https://www.coherentmarketinsights.com/market-insight/halitosis-treatment-market-2219
Key Takeaways of the Halitosis Treatment Market:
- The global halitosis treatment market is expected to expand at a CAGR of 10.5% during the forecast period (2018–2026), owing to increasing occurrence of halitosis due various factors such as increasing consumption of tobacco, alcohol and sugary foods, and prevalence of various gastrointestinal diseases and infection of nose and throat.
- Among region, the Asia Pacific is expected witness growth at highest rate during the forecast period, owing to increasing awareness among population about oral hygiene.
- Major players operating in the global halitosis treatment market include Abbott Laboratories, AstraZeneca Plc., Colgate-Palmolive Company, Dr. Harold Katz, Listerine, and Rowpar Pharmaceuticals
